<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="368114">
  <stage>Registered</stage>
  <submitdate>3/03/2015</submitdate>
  <approvaldate>13/04/2016</approvaldate>
  <actrnumber>ACTRN12616000486426</actrnumber>
  <trial_identification>
    <studytitle>Remote ischaemic preconditioning and its effect on coronary physiology and platelet &amp; leukocyte activation</studytitle>
    <scientifictitle>Remote ischaemic preconditioning and its effect on coronary physiology and platelet &amp; leukocyte activation in patients with suspected coronary artery disease undergoing coronary angiography.</scientifictitle>
    <utrn />
    <trialacronym>RIPPLE</trialacronym>
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Coronary artery disease</healthcondition>
    <conditioncode>
      <conditioncode1>Cardiovascular </conditioncode1>
      <conditioncode2>Coronary heart disease</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Patients will have remote ischaemic preconditioning delivered which involves inflating a sphygmomanometer to supra-systolic pressures around their arm. The sphygmomanometer will be inflated to 200mmHg or 50mmHg above systolic blood pressure for 5 minutes then deflated for 5 minutes. This cycle will be repeated 3 times. The treatment will be administered by a member of the research team. The participant will undergo the planned medical procedure after the remote ischaemic preconditioning.</interventions>
    <comparator>Sham remote ischaemic preconditioning will be delivered in an identical manner to remote ischaemic preconditioning except that the sphygmomanometer will be inflated to 10mmHg.</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Changes to measures of coronary artery flow as assessed with the use of a coronary pressure sensor wire.</outcome>
      <timepoint>Immediately after remote ischaemic preconditioning/sham</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Markers of platelet and leukocyte activation assessed by performing flow cytometry on blood samples collected from the patient. This is a composite outcome.</outcome>
      <timepoint>Immediately after remote ischaemic preconditioning/sham</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Nil</outcome>
      <timepoint>Nil</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Patients listed for coronary angiography +/- angioplasty and stenting</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Contraindications to remote ischaemic preconditioning- clinically unstable, peripheral vascular disease of upper limb, AVF in left arm, contraindications to adenosine, unable to co-operate/ consent, pre-existing neuropathy or myopathy</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1>True</masking1>
    <masking2>False</masking2>
    <masking3>True</masking3>
    <masking4>True</masking4>
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>17/10/2014</anticipatedstartdate>
    <actualstartdate>17/10/2014</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize>100</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>NSW</recruitmentstate>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>ANZAC research institute</primarysponsorname>
    <primarysponsoraddress>Hospital road Concord 2139 NSW</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Other</fundingtype>
      <fundingname>ANZAC research institute</fundingname>
      <fundingaddress>Hospital road Concord 2139 NSW</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>We are trying to establish the mechanism by which remote ischaemic preconditioning confers protection to the heart</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Sydney local health district HREC</ethicname>
      <ethicaddress />
      <ethicapprovaldate>6/06/2014</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate />
      <ethiccountry />
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Prof</title>
      <name>Leonard Kritharides</name>
      <address>Level 3 west, Cardiology department, Concord Hospital
Hospital road Concord NSW 2139</address>
      <phone>(+612) 97676296</phone>
      <fax />
      <email>leonard.kritharides@sydney.edu.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Jerrett Lau</name>
      <address>Level 3 west, Cardiology department, Concord Hospital
Hospital road Concord NSW 2139</address>
      <phone>(+612) 97676296</phone>
      <fax />
      <email>jerrett.lau@gmail.com</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Jerrett Lau</name>
      <address>Level 3 west, Cardiology department, Concord Hospital
Hospital road Concord NSW 2139</address>
      <phone>(+612) 97676296</phone>
      <fax />
      <email>jerrett.lau@gmail.com</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>